Mark Bagnall

Mark Bagnall is an Executive in Residence at Health2047 - an American Medical Association founded business accelerator in Silicon Valley targeting nascent opportunities to address chronic disease. As an entrepreneur and business manager specializing in the health care industry for well over 20 years, Mark had had the opportunity to found a few startups and advise and invest in many others.Mark is also ​CEO of Phenomix Sciences, an early stage startup providing healthcare solutions that will enable personalized management of chronic diseases (supported by AI) with better efficacy, fewer side effects, and lower costs.